WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010151551) ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/151551    International Application No.:    PCT/US2010/039530
Publication Date: 29.12.2010 International Filing Date: 22.06.2010
IPC:
A61K 31/535 (2006.01)
Applicants: MEDICINOVA, INC. [US/US]; 4350 La Jolla Village Drive, Suite 950 San Diego, CA 92122 (US) (For All Designated States Except US).
JOHNSON, Kirk, W. [US/US]; (US) (For US Only).
GROSS, Matthew, I. [US/US]; (US) (For US Only).
GAETA, Federico, C.A. [US/US]; (US) (For US Only)
Inventors: JOHNSON, Kirk, W.; (US).
GROSS, Matthew, I.; (US).
GAETA, Federico, C.A.; (US)
Agent: VILLACORTA, Gilberto M.; FOLEY & LARDNER LLP 3000 K Street, NW Washington, DC 20007 (US)
Priority Data:
61/219,664 23.06.2009 US
Title (EN) ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
(FR) COMPOSITIONS ÉNANTIOMÈRES DE 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-A]PYRIDINE-3-YL)PROPANE-1-ONE ET PROCÉDÉS CORRESPONDANTS
Abstract: front page image
(EN)Enantiomerically pure (S)-2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one, (S)-AV1013, is a candidate therapeutic for treating neuroathic pain, addiction behavior and drug withdrawal symptoms. Also described are methods for preparing and using (S)-AV1013, its pharmaceutically acceptable salts as well as pharmaceutically acceptable formulations of the same.
(FR)L'invention porte sur de la (S)-2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridine-3-yl)propane-1-one énantiomériquement pure, (S)-AV1013, qui est un candidat thérapeutique pour le traitement d'une douleur neuropathique, d'un comportement d'addiction et de symptômes de sevrage de médicament. L'invention porte également sur des procédés de préparation et d'utilisation de la (S)-AV1013, sur ses sels pharmaceutiquement acceptables ainsi que sur des formulations pharmaceutiquement acceptables de celles-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)